SPRC - MCAP CO - SciSparc Ltd

SciSparc Ltd (SPRC) implements automated software for clinical data analysis and robotic molecule screening. The business relies on the creation of unique cannabinoid blends that optimize dosages for neurological agents. Current market capitalization stands at 0.00. This chart of market value confirms management's strategy to minimize costs and protect profits amid risks within the Israeli micro-cap sector.

This metric is calculated by multiplying the current market price of a single share by the total number of outstanding securities. This figure reflects the aggregate market value of the business as determined by investor expectations. For SciSparc Ltd (SPRC), it serves as an indicator of confidence in its psychopharmaceutical developments. Valuation dynamics depend directly on the success of clinical drug trials. By analyzing the company's market capitalization, one can track the market's reaction to its expansion strategy.